<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Lecithin-cholesterol acyltransferase (LCAT) esterifies free cholesterol (FC) in plasma and plays a crucial role in the maturation of prebeta1-<z:chebi fb="17" ids="39025">HDL</z:chebi> (<z:chebi fb="23" ids="18059">lipid</z:chebi>-poor <z:chebi fb="17" ids="39025">HDL</z:chebi>) into alpha-migrating <z:chebi fb="17" ids="39025">HDL</z:chebi> (spherical <z:chebi fb="17" ids="39025">HDL</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>Natural mutations of LCAT gene cause familial <z:e sem="disease" ids="C0268239" disease_type="Disease or Syndrome" abbrv="">LCAT deficiency</z:e> (FLD) or <z:e sem="disease" ids="C0342895" disease_type="Disease or Syndrome" abbrv="FED">fish-eye disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FED</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The relationship between mutations and their phenotypes gives important clues to the functions of specific regions of LCAT </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated the first homozygous case with a substitution of threonine to methionine at codon 13 (T13M) of LCAT gene </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We evaluated LCAT activity, LCAT distribution among <z:chebi fb="17" ids="39025">HDL</z:chebi> subfractions and conversion of prebeta1-<z:chebi fb="17" ids="39025">HDL</z:chebi> to alpha-migrating <z:chebi fb="17" ids="39025">HDL</z:chebi> by native two-dimensional gel electrophoresis (N-2DGE) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The proband had <z:hpo ids='HP_0007759'>corneal opacity</z:hpo>, severe <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypo-alpha-lipoproteinemia</z:e>, half-<z:mpath ids='MPATH_458'>normal</z:mpath> LCAT activity and near <z:mpath ids='MPATH_458'>normal</z:mpath> cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi>/total cholesterol (TC) ratio in plasma </plain></SENT>
<SENT sid="6" pm="."><plain>These features were characteristic of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FED</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Plasma prebeta1-<z:chebi fb="17" ids="39025">HDL</z:chebi> concentration was near <z:mpath ids='MPATH_458'>normal</z:mpath>, but not converted to alpha-migrating <z:chebi fb="17" ids="39025">HDL</z:chebi> during 37 degrees C incubation </plain></SENT>
<SENT sid="8" pm="."><plain>As expected, alpha-migrating <z:chebi fb="17" ids="39025">HDL</z:chebi> (especially large particles) was markedly reduced </plain></SENT>
<SENT sid="9" pm="."><plain>In the immunoblot against LCAT, the small alpha-migrating <z:chebi fb="17" ids="39025">HDL</z:chebi> from the proband had much less LCAT in this patient than in controls </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: T13M mutation of LCAT gene causes <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FED</z:e> </plain></SENT>
</text></document>